Creative Medical Technology Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Creative Medical Technology Holdings, Inc. (CELZ) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 22.11 thousand shares for the 6-month period ending 2021-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2022-08-12
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2021-03-31 was 28.95M shares, a 94.85% decline year-over-year.
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2020-09-30 was 1.58M shares.
- Creative Medical Technology Holdings, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2020-03-31 was 562.26M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month as first filed |
|---|---|---|---|---|---|---|
| 2021-06-30 | 22.11K shares 10-Q · filed 2022-08-12 | 11.06M shares 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | 28.95M shares 10-Q · filed 2022-05-13 | |||||
| 2020-09-30 | 1.58M shares 10-Q · filed 2021-11-15 | 789.55M shares 10-Q · filed 2020-11-13 | 1.31M shares 10-Q · filed 2021-11-15 | 653.86M shares 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | 633.15M shares 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | 562.26M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |